A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

Conditions: Overweight; Obesity Interventions: Drug: BI 456906; Drug: Placebo to BI 456906; Drug: Moxifloxacin; Drug: Placebo to moxifloxacin Sponsors: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials